0
0
Read Time:12 Second
Marksans Pharma Limited has informed the Exchange regarding a press release dated November 05, 2025, titled “Marksans Pharma Limited s wholly owned subsidiary in UK, Relonchem Limited receives Marketing Authorization for its product Exemestane 25mg film-coated tablet.”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %